Sweden-based Moberg Pharma AB (OMX: MOB) has named Dr Cindy Wong as its new chief medical officer, it was reported on Thursday.

Prior to joining Moberg Pharma AB, Dr Wong was vice president and head of Global Clinical Development at Metz Pharmaceuticals GmbH. She has extensive international experience in clinical development and registration of new products in various treatment areas including Dermatology. She has served as vice president and head of Global Clinical Development at Metz Pharmaceuticals GmbH, chief medical officer at Q-Med/Galderma, and in senior positions at regulatory authorities in both Sweden and Australia.

Dr Wong has board certification in internal medicine and clinical immunology and is a medical graduate from the University of Adelaide and has completed postgraduate training in Internal Medicine, Clinical Immunology and Immunopathology.